Virginia Powers, PhD
Advertisement
Articles by Virginia Powers, PhD
Advertisement
Latest Updated Articles
Basiliximab Elicits High Response Rates After Haploidentical HSCT in Pediatric Acute GVHDPublished: September 8th 2020 | Updated:
Transplantation Using Haploidentical Donors Outperforms Matched Sibling Donors in MRD+ ALLPublished: September 9th 2020 | Updated:
First-Line Pembrolizumab Shows Substantial Activity in Advanced Bladder CancerPublished: October 10th 2016 | Updated:
Nivolumab/Cabozantinib Combo Shows Promise in GU CancersPublished: October 18th 2016 | Updated:
Long-Term Follow-Up Supports Frontline Dabrafenib/Trametinib in MelanomaPublished: October 20th 2016 | Updated:
Novel HER2-Targeting Antibody-Drug Conjugate Shows Broad Antitumor ActivityPublished: October 20th 2016 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
5